Boc3Arg-Linked Ligands Induce Degradation by Localizing Target Proteins to the 20S Proteasome.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  ACS Chemical Biology

• Publication date

  2016-10-18

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/ACSCHEMBIO.6B00656PMID 27704767PMCID PMC5524191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small-Molecule PROTACS: New Approaches to Protein Degradation.

  2016cited by this paper
• Inducing Protein Degradation as a Therapeutic Strategy.

  2016cited by this paper
• Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling*

  2016cited by this paper
• Naturally Occurring Isothiocyanates Exert Anticancer Effects by Inhibiting Deubiquitinating Enzymes.

  2015cited by this paper
• Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging.

  2015cited by this paper
• Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4

  2015cited by this paper
• Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4.

  2015cited by this paper
• Mechanistic insights into bacterial AAA+ proteases and protein-remodelling machines

  2015cited by this paper
• Phthalimide conjugation as a strategy for in vivo target protein degradation

  2015cited by this paper
• Regulating the 20S Proteasome Ubiquitin-Independent Degradation Pathway

  2014cited by this paper
• Targeted Protein Destabilization Reveals an Estrogen-mediated ER Stress Response

  2014cited by this paper
• PA28αβ: The Enigmatic Magic Ring of the Proteasome?

  2014cited by this paper
• A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

  2014cited by this paper
• Small Molecule-facilitated Degradation of ANO1 Protein

  2014cited by this paper
• Pharmacological Targeting of the Pseudokinase Her3

  2014cited by this paper
• Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.

  2014cited by this paper
• A bidirectional system for the dynamic small molecule control of intracellular fusion proteins.

  2013cited by this paper
• Identification of Hydrophobic Tags for the Degradation of Stabilized Proteins

  2012cited by this paper
• Degradation of damaged proteins: the main function of the 20S proteasome.

  2012cited by this paper
• Inhibitor mediated protein degradation.

  2012cited by this paper
• Chemical biology: Greasy tags for protein removal

  2012cited by this paper
• Subcellular Distribution and Dynamics of Active Proteasome Complexes Unraveled by a Workflow Combining in Vivo Complex Cross-Linking and Quantitative Proteomics*

  2012cited by this paper
• Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activity.

  2011cited by this paper
• Inhibition of proteasome deubiquitinating activity as a new cancer therapy

  2011cited by this paper
• Small-Molecule Hydrophobic Tagging Induced Degradation of HaloTag Fusion Proteins

  2011cited by this paper
• EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan

  2011cited by this paper
• Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.

  2010cited by this paper
• Highly site‐selective stability increases by glycosylation of dihydrofolate reductase

  2010cited by this paper
• Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.

  2010cited by this paper
• The ligand-free state of the TPP riboswitch: a partially folded RNA structure.

  2010cited by this paper
• Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.

  2009cited by this paper
• Cancer Preventive Isothiocyanates Induce Selective Degradation of Cellular α- and β-Tubulins by Proteasomes*

  2009cited by this paper
• Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.

  2009cited by this paper
• Proteasome regulators: activators and inhibitors.

  2009cited by this paper
• Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways

  2009cited by this paper
• Residence time of receptor-ligand complexes and its effect on biological function.

  2008cited by this paper
• Ubiquitin-independent degradation of proteins by the proteasome.

  2008cited by this paper
• Activation and inhibition of the proteasome by betulinic acid and its derivatives

  2007cited by this paper
• Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.

  2007cited by this paper
• Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.

  2007cited by this paper
• Preparation, characterization, and use of tagged ubiquitins.

  2005cited by this paper
• Faculty of 1000 evaluation for ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle.

  2005cited by this paper
• ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle.

  2005cited by this paper
• Localization to the Proteasome Is Sufficient for Degradation*

  2004cited by this paper
• Structure, dynamics, and catalytic function of dihydrofolate reductase.

  2004cited by this paper
• From magic bullets to designed multiple ligands.

  2004cited by this paper
• Binding of Hydrophobic Peptides to Several Non-catalytic Sites Promotes Peptide Hydrolysis by All Active Sites of 20 S Proteasomes

  2002cited by this paper
• Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy

  2002cited by this paper
• Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex.

  2000cited by this paper
• Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

  2000cited by this paper
• Hybrid Proteasomes

  2000cited by this paper
• Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis.

  2000cited by this paper
• Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

  2000cited by this paper
• Multistate equilibrium unfolding of Escherichia coli dihydrofolate reductase: thermodynamic and spectroscopic description of the native, intermediate, and unfolded ensembles.

  2000cited by this paper
• Multistate equilibrium unfolding of Escherichia coli dihydrofolate reductase: thermodynamic and spectroscopic description of the native, intermediate, and unfolded ensembles.

  2000cited by this paper
• Purification and characterization of a protein inhibitor of the 20S proteasome (macropain).

  1992cited by this paper

• Bridged PROTAC, DNA-based PROTAC and hydrophobic tag technologies for targeted protein degradation.

  2026cites this paper
• Recent Advances in Hydrophobic Tag-Based Targeted Protein Degraders

  2026cites this paper
• Hydrophobic tagging: A promising paradigm for targeted protein degradation

  2025cites this paper
• Contemporary trends in targeted protein degradation for neurodegenerative diseases.

  2025cites this paper
• Proteolysis targeting chimera, molecular glue degrader and hydrophobic tag tethering degrader for targeted protein degradation: Mechanisms, strategies and application.

  2025cites this paper
• Discovery of a first-in-class protein arginine methyltransferase 1 (PRMT1) degrader for nonenzymatic functions studies.

  2025cites this paper
• Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors.

  2025cites this paper
• Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions

  2025cites this paper
• Exploration of degrons and their ability to mediate targeted protein degradation.

  2025cites this paper
• Discovery of D-Ring-Contracted Artemisinin as a Potent Hydrophobic Tag for Targeted Protein Degradation.

  2025cites this paper
• Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation.

  2025cites this paper
• Ubiquitin E3 ligases assisted technologies in protein degradation: Sharing Pathways in Neurodegenerative Disorders and Cancer.

  2024cites this paper
• Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond

  2024cites this paper
• γ-Secretase Cleaves Bifunctional Fatty Acid-Conjugated Small Molecules with Amide Bonds in Mammalian Cells.

  2024cites this paper
• Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1

  2024cites this paper
• Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders.

  2024cites this paper
• Selective Protein Degradation through Tetrazine Ligation of Genetically Incorporated Unnatural Amino Acids.

  2024cites this paper
• Let's get biophysical - How to get your favorite protein's digits.

  2024cites this paper
• Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment.

  2024cites this paper
• Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways.

  2024cites this paper
• Potential acridinedione derivatives for the development of a heterobifunctional PROTAC for targeted degradation of PCSK9 protein

  2024cites this paper
• Engineered human H-chain ferritin with reversed charge of the internal cavity exhibits RNA-mediated spongelike effect for loading RNA/DNA-binding molecules.

  2024cites this paper
• Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.

  2023cites this paper
• Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution

  2023cites this paper
• Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: past, present and future perspectives

  2023cites this paper
• Hydrophobic tag-based protein degradation: Development, opportunity and challenge.

  2023cites this paper
• Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation.

  2023cites this paper
• Targeted Protein Degradation: Principles, Strategies, and Applications

  2023cites this paper
• A First-Class Degrader Candidate Targeting Both KRAS G12D and G12V Mediated by CANDDY Technology Independent of Ubiquitination

  2023cites this paper
• Targeting the Hedgehog pathway with novel Gli1 hydrophobic tagging degraders.

  2023cites this paper
• Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis

  2023cites this paper
• Targeted protein degradation in cancers: Orthodox PROTACs and beyond.

  2023cites this paper
• Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

  2023influential citation
• Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells

  2022cites this paper
• Targeted protein degraders march towards the clinic for neurodegenerative diseases.

  2022cites this paper
• Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity

  2022cites this paper
• Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections.

  2022cites this paper
• From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

  2021cites this paper
• [Induced degradation of proteins by PROTACs and other strategies: towards promising drugs].

  2021cites this paper
• Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors

  2021cites this paper
• Cancer Targets Involving the Ubiquitin Proteasome System

  2021cites this paper
• Advancing targeted protein degradation for cancer therapy

  2021cites this paper
• Induction of Apoptosis in Cancer Cells by Glutathione Transferase Inhibitor Mediated Hydrophobic Tagging Molecules.

  2021cites this paper
• Applications of Bacterial Degrons and Degraders — Toward Targeted Protein Degradation in Bacteria

  2021cites this paper
• Recent Advances in the Design and Development of anticancer molecules based on PROTAC technology.

  2020cites this paper
• The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents

  2020cites this paper
• Time to Get Turned on by Chemical Biology

  2020cites this paper
• Chimera induced protein degradation: PROTACs and beyond.

  2020cites this paper
• Significance of Selective Protein Degradation in the Development of Novel Targeted Drugs and Its Implications in Cancer Therapy

  2020cites this paper
• Emerging New Concepts of Degrader Technologies

  2020cites this paper
• Taking the Brakes Off Targeted Protein Degradation.

  2020cites this paper
• Chemical Biology Gateways to Mapping Location, Association, and Pathway Responsivity

  2019cites this paper
• Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs

  2019cites this paper
• From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

  2019cites this paper
• PROTACs– a game-changing technology

  2019cites this paper
• Inducing the Degradation of Disease-Related Proteins Using Heterobifunctional Molecules

  2019cites this paper
• Degradation of proteins by PROTACs and other strategies

  2019cites this paper
• Proteasome Activation to Combat Proteotoxicity

  2019cites this paper
• Emerging modes-of-action in drug discovery.

  2019cites this paper
• A critical evaluation of the approaches to targeted protein degradation for drug discovery

  2019cites this paper
• Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery

  2019cites this paper
• Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins

  2018influential citation
• New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons.

  2018cites this paper
• Chemical approaches to targeted protein degradation through modulation of the ubiquitin–proteasome pathway

  2017cites this paper
• Targeted Protein Degradation

  2017cites this paper
• Protein degradation: a validated therapeutic strategy with exciting prospects.

  2017cites this paper
• Selective Downregulation of JAK2 and JAK3 by an ATP-Competitive pan-JAK Inhibitor.

  2017cites this paper
• Small-Molecule Modulation of Protein Homeostasis.

  2017cites this paper
• Targeted protein knockdown using small molecule degraders.

  2017cites this paper
• Recognition of substrate degrons by E3 ubiquitin ligases and modulation by small-molecule mimicry strategies.

  2017cites this paper
• Chemical Methods to Knock Down the Amyloid Proteins

  2017cites this paper